Capital City Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,163
Closed -$299K 120
2023
Q2
$299K Sell
8,163
-371
-4% -$14.4K 0.09% 99
2023
Q1
$348K Buy
8,534
+354
+4% +$15.3K 0.11% 95
2022
Q4
$419K Sell
8,180
-100
-1% -$4.79K 0.14% 88
2022
Q3
$363K Sell
8,280
-955
-10% -$46.4K 0.13% 92
2022
Q2
$484K Buy
9,235
+771
+9% +$39.3K 0.16% 86
2022
Q1
$438K Buy
8,464
+2,816
+50% +$146K 0.13% 93
2021
Q4
$334K Buy
+5,648
New +$280K 0.09% 101
2019
Q2
Sell
-5,666
Closed -$228K 100
2019
Q1
$228K Buy
5,666
+249
+5% +$9.97K 0.1% 90
2018
Q4
$224K Buy
5,417
+348
+7% +$14.4K 0.1% 93
2018
Q3
$212K Buy
+5,069
New +$195K 0.09% 96
2017
Q1
Sell
-6,534
Closed -$201K 102
2016
Q4
$201K Buy
+6,534
New +$199K 0.08% 101
2014
Q1
Sell
-7,014
Closed -$204K 100
2013
Q4
$204K Sell
7,014
-364
-5% -$10.6K 0.09% 97
2013
Q3
$201 Buy
7,378
+1,401
+23% +$38.1K 0.09% 94
2013
Q2
$159K Buy
+5,977
New +$165K 0.07% 96

Other funds holding PFE

Capital City Trust's PFE Position: Q3 2023 in Review

Capital City Trust sold out of Pfizer (PFE) in Q3 2023, closing a stake of 8,163 shares — an estimated $299K sold.

Capital City Trust first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $484K in Q2 2022. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Capital City Trust reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Capital City Trust sold 8,163 Pfizer shares in Q3 2023, an estimated $299K.
  • Capital City Trust first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Capital City Trust's Pfizer position peaked at $484K in Q2 2022.
  • 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Capital City Trust's 13F filing for Q3 2023, filed 12 Oct 2023.